Skip to content

Fluoroslide Pneumocystis Carinii (IFA) Assay

by Disease Detection International, Inc.

510(k) K884047

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK884047 Date14 Mar 1989ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
LYF
Device Class
Class II
Regulation
21 CFR Part 866.3780
Advisory Committee
Microbiology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 27 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Fluoroslide Pneumocystis Carinii (IFA) Assay is an immunofluorescent reagent used to identify Pneumocystis carinii from clinical specimens. It is classified as a Class II medical device under the Microbiology specialty and is identified by product code LYF.

The device is supplied as a reagent kit for in vitro diagnostic use. It received FDA 510(k) clearance (K884047) on March 14, 1989, and is substantially equivalent to a legally marketed predicate device. The assay is intended for use in laboratory settings to aid in the diagnosis of Pneumocystis carinii infection.

Other devices from Disease Detection International, Inc.

See all devices from Disease Detection International, Inc. →

Questions

AI-generated answers, 27 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Fluoroslide Pneumocystis Carinii (IFA) Assay used for?

    The Fluoroslide Pneumocystis Carinii (IFA) Assay is an immunofluorescent reagent used to identify Pneumocystis carinii from clinical specimens, aiding in the diagnosis of Pneumocystis carinii infection in laboratory settings.

  • How is the Fluoroslide Pneumocystis Carinii (IFA) Assay supplied and intended for use?

    The device is supplied as a reagent kit for in vitro diagnostic use and is intended for use in laboratory settings to aid in the diagnosis of Pneumocystis carinii infection from clinical specimens.

  • What regulatory clearance does the Fluoroslide Pneumocystis Carinii (IFA) Assay have?

    The Fluoroslide Pneumocystis Carinii (IFA) Assay received FDA 510(k) clearance (K884047) on March 14, 1989, and is classified as a Class II medical device under the Microbiology specialty with product code LYF.